The President of Vietnam, Nguyen Xuan Phuc, thanked this Sunday in Havana for Cuba’s “willingness” to transfer the technology to produce the Abdala anticovid vaccine to his country.
SIGHT: Long-Term COVID-19: How Much Does It Affect Children?
“Thank you very much, Cuba (…) for the willingness to cooperate for the production of Abdala in Vietnam”, Nguyen said this Sunday during a meeting with Prime Minister Manuel Marrero, according to state television.
In the afternoon, the Vietnamese president was received with military honors at the Palace of the Revolution by his counterpart Miguel Díaz-Canel, who imposed on him the José Martí order, the highest Cuban distinction.
SIGHT: COVID-19 in Peru: More than 47,000 possible cases of reinfection detected
After holding official talks, both leaders endorsed lsigning of “cooperation” agreements in health areas, cybersecurity, construction, justice and aquaculture, according to images released by Cuban television.
Cuba began exchanges with experts from the WHO for the recognition of its anticovid vaccines Abdala and Soberana 02, which, according to its creators, are more than 90% effective against the appearance of symptoms of the disease.
SIGHT: Is there evidence that vitamin D protects against severe COVID-19? This says science
Marta Ayala, director of the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, which created the Abdala vaccine, explained this Sunday to AFP that “Work continues on the technology transfer process of the final stage of Abdala with Vietnam ”.
If the agreement is finalized, Vietnam would be the first country outside of Cuba to produce this vaccine, whose emergency use approved on Saturday, coinciding with the arrival of its president in Havana.
Heavily affected by the slowness of its vaccination campaign, Vietnam is currently experiencing a severe outbreak of the coronavirus.
On Saturday, the CIGB and Vietnam’s Center for Research and Production of Vaccines and Medical Biologicals (POLYVAC) signed a memorandum of understanding with a view to “Expand their relationships, collaborating on other issues of mutual interest, such as dengue, Zika.”
Cuban vaccines are based on a recombinant protein, the same technique in which the American company Novavax and the French Sanofi are working.
According to the criteria of
IT MAY INTEREST YOU:
Follow us on twitter: